High glucose • High-mobility group box-1 • MyD88 • Spleen tyrosine kinase • Toll-like receptor 4 • Transforming growth factor-β1 Abstract Background/Aims: High glucose activates spleen tyrosine kinase (Syk) in human proximal tubular epithelial cells (HK-2 cells), which leads to NF-κB activation and transforming growth factor-β1 (TGF-β1) production. We explored the signal transduction pathway from high glucose to Syk activation. Methods: The pathway was evaluated by siRNA transfection, immunoprecipitation and Western blot. Results: High glucose stimulated Syk activation within 10 min. Depletion of toll-like receptor 4 (TLR4) attenuated high glucose-induced Syk activation, NF-κB p65 nuclear translocation, and TGF-β1 production. In addition, TLR4 inhibitor (CLI-095), TLR4-neutralizing antibody, and depletion of myeloid differentiation factor 88 (MyD88) all attenuated high glucose-induced Syk activation. As an evidence of TLR4 activation, interleukin-1 receptor-associated kinase 1 was recruited to MyD88 and TLR4 upon exposure to high glucose. Syk was co-immunoprecipitated with TLR4, and Syk bound to TLR4 was activated by high glucose. High-mobility group box-1 (HMGB-1), an endogenous activator of TLR4, rapidly increased in TLR4 immunoprecipitates upon high glucose stimulation, and this association was reduced by N-acetylcysteine, an antioxidant. An HMGB-1 inhibitor glycyrrhizin suppressed high glucose-induced Syk activation. Conclusion: Syk is constitutively associated with TLR4. High glucose induces an immediate, reactive oxygen species-dependent, extracellular release of HMGB-1 which binds to TLR4 and activates it, leading to Syk activation.
Introduction
Spleen tyrosine kinase (Syk) is a non-receptor protein tyrosine kinase, which transmits B-cell antigen receptor or Fc-receptor signaling of hematopoietic cells including mast cells, lymphocytes, neutrophils and monocytes, and thereby regulates the immune response [1] . In chronic inflammatory diseases including allergic asthma and rheumatoid arthritis, Syk plays a crucial role in the pathogenesis and has become a new promising therapeutic target [2] .
Besides the hematopoietic cells, Syk is widely distributed in many other types of cells [3] . Our previous studies suggested that Syk might be implicated in the diabetic kidney disease. In cultured human glomerular endothelial cells [4] , we found that high glucose rapidly activates Syk, which leads to tyrosine phosphorylation of IκBα and thereby activates nuclear factor-κB (NF-κB), suggesting that Syk could be an important mediator in the intracellular signal transduction for high glucose-induced cytokine production that is dependent on NF-κB activation, including chemokine (C-C motif) ligand 2 (CCL2). Similarly, in human proximal tubular epithelial cells [5] , high glucose activated Syk, which in turn resulted in activations of activator protein-1 (AP-1) and NF-κB, leading to transforming growth factor-β1 (TGF-β1) gene expression. As such, Syk plays an important role in high glucose signal transduction, but it remains unknown how high glucose stimulates Syk activation.
Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns that are expressed on infectious agents such as lipopolysaccharides (LPS) in Gram-negative bacteria, and mediate the production of cytokines necessary for the development of effective immunity [6] . In neutrophils [7] , monocytes [8] and macrophages [9] , Syk is associated with toll-like receptor 4 (TLR4), and plays a key role in the signal transduction of TLR4 that is activated by LPS. In addition to binding exogenous ligands derived from pathogens, TLRs interact with endogenous molecules released from damaged tissues and regulate many sterile inflammation processes [10] . Recent studies have shown that TLR4 is also implicated in the pathogenesis of diabetic nephropathy [11] [12] [13] [14] . High glucose stimulated TLR4 gene transcription and thereby its protein expression in tubular epithelial cells and mesangial cells, while TLR4 antagonist or deficiency of TLR4 had protective effects on diabetic nephropathy. Though high glucose was shown to induce TLR4 expression, it is not known whether TLR4 directly participates in high glucose signal transduction and regulates Syk activation before its expression is increased.
In the present study, therefore, we explored the signal pathway from high glucose to Syk activation by investigating the interaction between TLR4 and Syk in human proximal tubular epithelial cells (HK-2 cells).
Materials and Methods
Materials D-glucose and glycyrrhizin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Protein A/G-PLUS Agarose and antibodies to human TLR4 (for immunoprecipitation, HTA-125 that detects TLR4/ myeloid differentiation factor 2 complex; for immunoblot, H-80 that detects TLR4), myeloid differentiation factor 88 (MyD88), interleukin-1 receptor-associated kinase 1 (IRAK-1), high-mobility group box-1 (HMGB-1), p65, Syk, TGF-β1, actin, and histone H3 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody to human phospho-Syk (pY525) was purchased from Epitomics (clone EP575(2)Y, Burlingame, CA, USA). Neutralizing anti-TLR4 and control IgG antibodies were from eBioscience (San Diego, CA, USA). TLR4-siRNA, MyD88-siRNA and control-siRNAs were from Life Technologies (Ambion  ; Seoul, Korea). CLI-095 was from InvivoGen (San Diego, CA, USA). . Before each experiment, the cells were growtharrested for 72 h in serum-free DMEM media (Life Technologies) containing 5.5 mM glucose. The 72 h rest was adopted to make the experimental condition same with our previous study [5] , in which we tested the effect of high glucose on TGF-β1 mRNA and protein expression. It required a time for TGF-β1 mRNA of the cells cultured in the media containing FBS to decline to basal level after deprivation of FBS, and the stimulatory effect of high glucose on TGF-β1 mRNA was most consistent after 72 h starvation. To determine the signal transduction pathway from high glucose to Syk activation, HK-2 cells were treated with 5.5 or 30 mM glucose for different times, depending on the signal molecules to be evaluated. In the experiments using signal inhibitors including CLI-095 and N-acetylcysteine, the cells were preincubated with the inhibitors for 30 min before high glucose stimulation. In case of glycyrrhizin, it was added simultaneously with high glucose stimulation.
Cell culture and treatment
Transfection of siRNA Cells (1×10 5 cells) seeded in a 6-well plate and cultured for 24 h were transfected with TLR4-siRNA, MyD88-siRNA or a nonspecific, scrambled, control-siRNA using Lipofectamine ® Reagent (Life Technologies). In brief, 100 pmol siRNAs were mixed and incubated with 10 μl of lipofectamine reagent diluted in Opti-MEM ® medium (Life Technologies) without antibiotics for 15 minutes at room temperature to allow siRNAlipofectamine complexes to form. The siRNA-lipofectamine complexes were added to each culture dish containing fresh medium without serum, and incubated at 37 °C in a CO 2 incubator for 6 h. Thereafter, the medium was replaced with complete growth medium containing serum, and the cells were further incubated for 18 h. After then, the cells were placed in serum-free DMEM media (glucose 5.5 mM) for 72 h and subjected to the experiment.
Western blot analysis
To obtain whole cell lysate, the treated cells were washed with phosphate buffered saline (PBS), and lysed on ice for 10 min in 100 μl of lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, protease and phosphatase inhibitors. After centrifugation for 20 minutes at 4°C (10,000 g), the supernatant was obtained as whole cell lysate. To obtain nuclear protein, the treated cells were at first treated with lysis buffer A (25 mM Hepes (pH 7.9), 50 mM KCl, 0.5% Igepal CA-630, protease and phosphatase inhibitors) on ice for 10 min. The cell lysates were centrifuged for 5 minutes at 4°C (800 × g) and the supernatant (cytosolic fraction) was removed. The pellet was washed twice with washing buffer (25 mM Hepes (pH 7.9), 50 mM KCl, protease and phosphatase inhibitors) and centrifugation for 5 minutes at 4°C (800 × g). The remaining pellet was lysed again with lysis buffer B (25 mM Hepes (pH 7.9), 500 mM KCl, 10% glycerol, protease and phosphatase inhibitors) and subjected to repeated freezing and thawing with liquid nitrogen and a water bath set to 37 °C. Thereafter, the nuclear lysates were incubated at 4 °C for 20 min on a rocking platform. Finally, nuclear protein was obtained after centrifugation for 20 minutes at 4°C (10,000 × g). Equal amounts of whole cell lysates or nuclear proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 9 ~ 15% gels and transferred to an Immobilon-P membrane (Millipore, Bedford, MA, USA). The membrane was probed with the respective primary antibody. Bands were visualized using horseradish peroxidase conjugated secondary antibodies and the enhanced chemiluminescence agent (Luminata TM Forte Western HRP Substrate; Millipore).
Immunoprecipitation
The treated cells were lysed on ice as in Western blot, and whole cell lysates were obtained. The cell lysates (500 µg) were incubated with 5 µg of antibody to TLR4 (HTA-125) or MyD88 for 2 h at 4 °C, and then incubated with protein A/G-agarose beads at 4 °C under rotary agitation for 16 h. After washing with PBS, the protein A/G-agarose beads were recovered after centrifugation for 5 minutes at 4 °C (10,000 × g), and resuspended in sample buffer, boiled for 10 min, and analyzed by Western blotting.
Statistical analysis
Data are presented as means ± SE (standard error), with n representing the number of different experiments. An analysis of variance with Dunnett multiple-comparisons test was used to determine statistically significant differences between groups. A p value of <0.05 was considered statistically significant. 
Results

High glucose rapidly activates Syk
In our previous study, high glucose activated Syk, which led to activation of NF-κB and increased TGF-β1 production [5] . Phosphorylation of tyrosines 525 and 526 of human Syk, which are located in the activation loop of the Syk kinase domain, is essential for its function [15] . Consistent with our previous study, high glucose increased Tyr525 phosphorylation of Syk within 10 min in a time-and concentration-dependent manner, while mannitol did not (Fig. 1) .
Depletion of TLR4 attenuates high glucose-induced Syk activation, NF-κB p65 nuclear translocation, and TGF-β1 production
To explore whether TLR4 mediates high glucose-induced Syk activation, we transfected HK-2 cells with control-siRNA or TLR4-siRNA, and incubated them with 5.5 or 30 mM glucose for 10 min and then assessed Syk activation in the immunoblot of whole cell lysates. Depletion of TLR4 by transfection of TLR4-siRNA abolished high glucose-induced Syk activation, while control-siRNA did not ( Fig. 2A) .
The major form of NF-κB is composed of a dimer of p50 and p65 subunits, and is sequestered in the cytoplasm through its tight association with specific inhibitory proteins (IκB) [16] . When activated, NF-κB dissociates from IκB and translocates to the nucleus and binds to a specific sequence in DNA, which in turn results in gene transcription. To assess the effect of specific depletion of TLR4 on nuclear translocation of p65 protein, we transfected control-siRNA or TLR4-siRNA into the cells and then incubated the cells with 5.5 or 30 mM glucose for 30 min. The amount of p65 in nuclear protein was analyzed by Western blot. As shown in Fig. 2B , TLR4-siRNA abolished high glucose-induced p65 nuclear translocation.
To evaluate the effect of depletion of TLR4 on high glucose-induced TGF-β1 production, we transfected HK-2 cells with control-siRNA or TLR4-siRNA, and then incubated them with 5.5 or 30 mM glucose for 24 h. Western blot analysis of whole cell lysates was performed using ant-TGF-β1 antibody. High glucose significantly increased total amount of TGF-β1 protein as compared with control. By contrast, depletion of TLR4 by transfection of TLR4-siRNA abolished high glucose-induced TGF-β1 production (Fig. 2C) .
Inhibition of TLR4 attenuates high glucose-induced Syk activation
CLI-095, also known as TAK-242, selectively binds to TLR4 and interferes with the interactions between TLR4 and its adaptor molecules, TIRAP and TRAM [17] . We evaluated the effect of TLR4 inhibitor on high glucose-induced Syk activation. As shown in Fig. 3A , phosphorylation of Syk was increased by high glucose, while this increase was attenuated by CLI-095. 
Cellular Physiology and Biochemistry
We also tested whether high glucose treatment is able to activate TLR4-MyD88 axis by measuring the recruitment of IRAK-1. HK-2 cells were incubated with 30 mM glucose for 0, 5, 10 or 20 min, and whole cell lysates were immunoprecipitated with an antibody against MyD88 or TLR4 and then the immune complexes were subjected to immunoblot analysis with an antibody against IRAK-1. High glucose treatment rapidly increased the bindings of IRAK-1 to MyD88 and TLR4, as shown in Fig. 4B and 4C .
Syk is associated with TLR4
Next, we explored the interaction between TLR4 and Syk. HK-2 cells were incubated with 30 mM glucose for 0, 5, 10 or 20 min. Cell lysates were immunoprecipitated with an antibody against TLR4, and then the immune complexes were subjected to immunoblot analysis with an antibody against p-Syk and Syk. As shown in Fig. 5 , Syk was co-immunoprecipitated with TLR4. High glucose did not increase the amount of Syk co-immunoprecipitated with TLR4, but increased phosphorylation of Syk bound to TLR4. 
HMGB-1 in high glucose-induced TLR4 activation
HMGB-1 is an endogenous activator of TLR4. We further explored whether HMGB-1 is involved in the activation of high glucose-induced TLR4 activation. HK-2 cells were incubated with 30 mM glucose for 0, 2.5, 5, 7.5 or 10 min, and cell lysates were immunoprecipitated with an antibody against TLR4, and then the immune complexes were subjected to immunoblot analysis with an antibody against HMGB-1. As shown in Fig. 6A , high glucose increased the amount of HMGB-1 that was co-immunoprecipitated with TLR4. On the other hand, inhibition of HMGB-1 by glycyrrhizin suppressed high glucose-induced Syk activation (Fig. 6B) . The association of HMGB-1 with TLR4 after high glucose treatment was reduced by pretreatment with N-acetylcysteine (Fig. 6C) . Consistent with it, high glucose-induced Syk activation was inhibited by N-acetylcysteine (Fig. 6D) .
Discussion
Our previous studies [4, 5] have shown that Syk is rapidly activated by high glucose and transmits high glucose signal leading to gene transcriptions of CCL2 and TGF-β1, which could be implicated in the development of diabetic nephropathy. The pathway from high glucose to Syk activation, however, remains to be elucidated. Our data in the present study suggest the signal pathway as follows; Syk is constitutively associated with TLR4. High glucose induces an immediate extracellular release of HMGB-1 which binds and activates TLR4, leading to Syk activation.
In animal studies of diabetic nephropathy, inhibition of TLR4 conferred protective effects on albuminuria, renal dysfunction, renal cortical NF-κB activation, tubular CCL2 expression, and interstitial macrophage infiltration [12] . In vitro studies also showed that high glucose stimulates TLR4 gene transcription and its protein expression, while depletion of TLR4 resulted in reduction of NF-κB activation and resulting in downregulation of IL-6 and CCL2 expressions [11] . However, it is not known whether TLR4 participates in high glucose signal transduction before its expression is increased. Incubation of HK-2 cells in high glucose activates Syk within 10 min. In the present study, depletion TLR4 by transfection of TLR4-siRNA attenuated high glucose-induced Syk activation and the downstream events including NF-κB p65 nuclear translocation and TGF-β1 production. In addition, preincubation of HK-2 cells with TLR4 inhibitor (CLI-095) or TLR4-neutralizing antibody attenuated high glucoseinduced Syk activation. MyD88 is an adaptor molecule of TLR4, and engagement of LPS to TLR4 induces the binding of IRAK-1 to MyD88, which transmits the LPS signal. Like LPS, high glucose rapidly induced the association of IRAK-1 to MyD88 and thereby to TLR4. These findings indicate that TLR4 is rapidly activated after high glucose stimulation and transmits the signal. Upon stimulation with high glucose, reactive oxygen species are produced and induce extracellular release of HMGB-1. HMGB-1 binds to TLR4 and activates it, which in turn leads to activation of Syk that is associated with TLR4. Activation of Syk leads to NF-κB activation and finally TGF-1 gene transcription. Abbreviations: HMGB-1, high-mobility group box-1; MD-2, myeloid differentiation factor 2; NF-κB, nuclear factor-κB; Syk, spleen tyrosine kinase; TLR4, toll-like receptor 4; TGF-β1, transforming growth factor-β1.
The role of Syk in intracellular signal transductions has been studied mainly in hematopoietic cells [1] , and Syk was found to form a complex with TLR4 in neutrophils, monocytes and macrophages [7] [8] [9] . The N-terminal SH2 domain of Syk was suggested to interact with the cytoplasmic TIR domain of TLR4 [18] . This interaction is constitutive because Syk is associated with TLR4 in the absence of any stimuli. Stimulation with LPS in neutrophil was shown to further increase Syk binding to TLR4, with an increase in Syk activation [7] . In another study of monocyte, however, LPS did not increase the association between TLR4 and Syk [8] , but induced the activation of Syk that is constitutively bound to TLR4. In the present study, Syk in HK-2 cells was co-immunoprecipitated with TLR4 in the resting state and thus Syk was constitutively associated with TLR4, as in the hematopoietic cells. High glucose did not increase the association of Syk to TLR4, but stimulated the activation of Syk co-immunoprecipitated with TLR4. Since Syk mediates high glucose signal leading to TGF-β1 production and the activation of Syk was dependent on TLR4 as noted above, Syk bound to TLR4 seems to play a key role in the signal transduction of TLR4 that is activated by high glucose.
TLR4 signaling has been known to occur via two pathways; MyD88-dependent pathway (TIRAP-MyD88-IRAK) and MyD88-independent pathway (TRAM-TRIF-IRF3) [6] . Depending on the nature of stimuli, TLR4 signaling occurs via recruitment of different adaptor molecules to the cytoplasmic domain of the receptor, thus resulting in different cellular responses [19] . In macrophage, minimally oxidized low-density lipoprotein stimulated intracellular reactive oxygen species (ROS) generation via TLR4 and Syk activation, while depletion of MyD88 did not alter the ROS production. Thus, Syk was suggested to be another TLR4 adaptor molecule [9] . In case of HK-2 cells in the present study, depletion of MyD88 attenuated high glucoseinduced Syk activation. Along with the finding of the increased binding of IRAK-1 to MyD88 implying activation of MyD88, it suggests that MyD88 is also implicated in high glucoseinduced Syk activation.
Another question addressed in this study was how TLR4 is rapidly activated by high glucose. TLRs interact with endogenous substances, i.e., damage-associated molecular pattern molecules (DAMPs), as well as pathogen-associated molecular patterns [10] . DAMPs are released from cells in response to injury, infection, or other inflammatory stimuli and activate TLRs and thereby mediate systemic inflammatory responses [20] . HMGB-1 is a nonhistone nuclear protein that is expressed constitutively in mammalian cells and contributes to stabilization of nucleosomes, DNA repair and recombination, and transcription [21] . Under stress conditions, it is released from the cells and functions as a DAMP. Recent studies have shown that high glucose induces HMGB-1 translocation from nucleus to cytosol and extracellular release [22, 23] . ROS are also known to induce extracellular release of HMGB-1 [24] . Because it is well-known that high glucose induces ROS generation, it may cause extracellular release of HMGB-1 through ROS. In these studies [22, 24] , the increase of HMGB-1 in culture media was significant only after several hours of exposure to high glucose or ROS, as measured by ELISA or western blot. The delayed release of HMGB-1 does not account for the early activation of TLR4 shown in the present study. However, our data suggests that HMGB-1 is released immediately. HMGB-1 was co-immunoprecipitated with TLR4, and the amount of HMGB-1 bound to TLR4 began to increase as early as 2.5 min after exposure to high glucose with a peak at 5 min and then decreased. In contrast, glycyrrhizin, an inhibitor of HMGB-1, suppressed high glucose-induced Syk activation when it was added simultaneously with high glucose stimulation. Thus, HMGB-1 seems to be rapidly released by high glucose, and binds and activates TLR4 on the cell surface. Reduction of the amount of HMGB-1 co-immunoprecipitated with TLR4 by N-acetylcysteine, an antioxidant, suggests that the release of HMGB-1 is dependent on ROS produced by high glucose stimulation.
In summary, Syk in HK-2 cells is constitutively associated with TLR4 as in hematopoietic cells. Upon stimulation with high glucose, TLR4 is immediately activated by HMGB-1, which in turn leads to activation of Syk that is associated with TLR4 (Fig. 7) . In this way, TLR4/Syk complex plays a key role in high glucose signal transduction. 
